ADAM8 is expressed widely in breast cancer and predicts poor outcome in hormone receptor positive, HER-2 negative patients
Stefania Pianetti(Tufts University), Nora D. Mineva(Boston University)
Cited by 6
Related Papers
CD40 Ligand-mediated Activation of the de Novo RelB NF-κB Synthesis Pathway in Transformed B Cells Promotes Rescue from Apoptosis
|Journal of Biological Chemistry|2007|44